Despite proposed new statement, question remains over the extent to which Makan Delrahim’s FRAND policy will find approval with the man likely to be the next Attorney General
IAM uncovers the patents-in-suit, runs down the two sides’ validity wins and losses so far, and provides much more analysis of yesterday's shock preliminary injunction in the Intermediate People's Court of Fuzhou
Former collaboration partner E Ink picks up nearly 800 patents; assignments reveal almost as many rights sold to OLED startup last year
World’s largest mobile operator pledges not to collect licence fees on 5G contributions which reports say have generated nearly 1,000 patent applications
An in-depth analysis shows that the American medical device manufacturer may not gain much in terms of quantity from its $4 billion purchase, but that the British healthcare company’s IP assets will boost its peripheral interventional offerings
Days after announced trade truce, China’s government explains ‘social credit score’ consequences for IP infringers first floated three years ago. Penalties range from borrowing restrictions to air travel bans.
John LaBarre's move to a biotech start-up follows previous departures of Allen Lo and Jeremiah Chan to Facebook, and is further evidence of the narrowing IP strategy gap between high-tech and the life sciences
The SUCCESS Act reads as a feel-good piece of legislation that acknowledges the growing role of underrepresented classes in the innovation ecosystem. However, it maintains the USPTO's controversial fee-setting authority.
After setback in Huawei suit, latest court cases show the state-funded Korean research institute is behind massive licensing programme
Boards and directors typically prioritise non-IP issues on the corporate agenda; however, legal requirements and market activities suggest that this might be a serious misstep.
Previous FRAND-related rulings indicate judges in China could set a global rate, would adopt the hard-edged non-discrimination obligation and would consider the parties' negotiation behaviours when reaching their decisions
There is not much time left to make nominations for the 2019 edition of IAM Strategy 300, our exclusive guide on the world's best IP strategists.
For over half a century Dolby Labs has worked hard to ensure that the company’s IP strategy is always aligned with its overall business goals. Its success in doing this teaches valuable lessons.
The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative.
Life sciences companies in the United States are under increasing pressure. Campaigners for changes to the patent system are working to prevent what they see as abusive practices – and it looks as if they are winning the argument.